Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines
Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.
Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines Read More »
